Beata Jagielska

Warsaw, MZ 02781, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Cardio-oncology: the Polish National Oncology Network model.

Cardio-oncology: the Polish National Oncology Network model.

Journal: European heart journal
Published: April 09, 2026

In the framework of the EU Trio Presidency-supporting the European Code Against Cancer.

In the framework of the EU Trio Presidency-supporting the European Code Against Cancer.

Journal: The Lancet regional health. Europe
Published: August 13, 2025

The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology.

The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology.

Journal: Expert review of pharmacoeconomics & outcomes research
Published: November 28, 2022

Making Sure That Orphan Incentives Tip the Right Way in Europe.

Making Sure That Orphan Incentives Tip the Right Way in Europe.

Journal: Healthcare (Basel, Switzerland)
Published: July 21, 2022

European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.

European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.

Journal: The Lancet. Oncology
Published: June 27, 2022

Perfusion-Diffusion Ratio: A New IVIM Approach in Differentiating Solid Benign and Malignant Primary Lesions of the Liver.

Perfusion-Diffusion Ratio: A New IVIM Approach in Differentiating Solid Benign and Malignant Primary Lesions of the Liver.

Journal: BioMed research international
Published: July 27, 2021

PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells.

PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells.

Journal: Cancers
Published: June 29, 2021

Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.

Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.

Journal: Cancers
Published: August 12, 2020

Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.

Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.

Journal: Biomedicine hub
Published: July 29, 2020

Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?

Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?

Journal: Biomedicine hub
Published: May 04, 2020

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015-2018 Years.

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015-2018 Years.

Journal: Frontiers in pharmacology
Published: April 06, 2020

Cardiotoxicity danger in immunotherapy.

Cardiotoxicity danger in immunotherapy.

Journal: IUBMB life
Published: December 15, 2019
Showing 1-12 of 20

Last Updated: 09/26/2026